Page last updated: 2024-10-17

bupropion and Heart Diseases

bupropion has been researched along with Heart Diseases in 10 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research Excerpts

ExcerptRelevanceReference
"Nicotine dependence is a significant addiction with many health consequences."6.47Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy. ( Grief, SN, 2011)
" Varenicline is a smoking cessation pharmacological therapy able to improve the possibilities to successfully achieve this result."3.81Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report. ( Boffi, R; Marabelli, C; Munarini, E; Pozzi, P, 2015)
"Bupropion overdose commonly causes generalized seizures and central nervous system depression."3.79Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. ( Al-Abri, SA; Benowitz, NL; Hayashi, S; Olson, KR; Orengo, JP; Thoren, KL, 2013)
"Nicotine dependence is a significant addiction with many health consequences."2.47Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy. ( Grief, SN, 2011)
" They have apparently safe cardiac safety profiles in both therapeutic and supra-therapeutic doses."1.32Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. ( Biswas, AK; Mayes, KL; Morris-Kukoski, CL; Zabrocki, LA, 2003)
" They have apparently safe cardiac safety profiles in both therapeutic and supratherapeutic doses, but recently the Federal Drug Administration has issued a caution regarding ziprasidone use in combination with other drugs that are known to prolong the QTc interval."1.32Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. ( Biswas, AK; Mayes, KL; Morris-Kukoski, CL; Zabrocki, LA, 2003)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's4 (40.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Olawuyi, O1
Mathieson, K1
Al-Abri, SA1
Orengo, JP1
Hayashi, S1
Thoren, KL1
Benowitz, NL1
Olson, KR1
Munarini, E1
Marabelli, C1
Pozzi, P1
Boffi, R1
Grief, SN1
Biswas, AK2
Zabrocki, LA2
Mayes, KL2
Morris-Kukoski, CL2
Roose, SP2
Spatz, E1
Dunlop, H1
Dalack, GW1
Glassman, AH1
Woodring, S1
Walsh, BT1
Giardina, EG1

Reviews

2 reviews available for bupropion and Heart Diseases

ArticleYear
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
    Primary care, 2011, Volume: 38, Issue:1

    Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Huma

2011
Treatment of depression in patients with heart disease.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Comorbidity;

1999

Other Studies

8 other studies available for bupropion and Heart Diseases

ArticleYear
Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
    Current drug safety, 2020, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Bupropion; Fema

2020
Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.
    Clinical toxicology (Philadelphia, Pa.), 2013, Volume: 51, Issue:10

    Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxins; Drug Overdose; Electrocard

2013
Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report.
    Journal of medical case reports, 2015, Feb-13, Volume: 9

    Topics: Bupropion; Counseling; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoki

2015
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Journal of toxicology. Clinical toxicology, 2003, Volume: 41, Issue:1

    Topics: Adult; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupro

2003
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Journal of toxicology. Clinical toxicology, 2003, Volume: 41, Issue:2

    Topics: Adolescent; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents;

2003
Bupropion (Zyban, sustained-release tablets): update.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jan-11, Volume: 162, Issue:1

    Topics: Bupropion; Canada; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Hypoglycemia; Seizures; Smoki

2000
[Antismoking pills for cardiac patients, too? Every third one rebounds].
    MMW Fortschritte der Medizin, 2002, Feb-21, Volume: 144, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Bupropion; Clinical Trials as Topic; Dopam

2002
Cardiovascular effects of bupropion in depressed patients with heart disease.
    The American journal of psychiatry, 1991, Volume: 148, Issue:4

    Topics: Aged; Aged, 80 and over; Antidepressive Agents; Blood Pressure; Bupropion; Cardiovascular System; De

1991